nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT1A1—hematologic cancer	0.194	0.676	CbGaD
Losartan—ALB—hematologic cancer	0.0476	0.166	CbGaD
Losartan—ABCB1—hematologic cancer	0.0454	0.158	CbGaD
Losartan—UGT1A1—Nilotinib—hematologic cancer	0.0174	0.0403	CbGbCtD
Losartan—UGT2B7—Epirubicin—hematologic cancer	0.0142	0.0329	CbGbCtD
Losartan—CYP1A2—Anagrelide—hematologic cancer	0.0139	0.0323	CbGbCtD
Losartan—UGT1A1—Irinotecan—hematologic cancer	0.0119	0.0277	CbGbCtD
Losartan—UGT1A1—Etoposide—hematologic cancer	0.00956	0.0222	CbGbCtD
Losartan—CYP2C9—Bexarotene—hematologic cancer	0.0087	0.0202	CbGbCtD
Losartan—ABCB1—Lenalidomide—hematologic cancer	0.00844	0.0196	CbGbCtD
Losartan—SLCO1B1—Irinotecan—hematologic cancer	0.00827	0.0192	CbGbCtD
Losartan—CYP2C8—Bortezomib—hematologic cancer	0.00764	0.0177	CbGbCtD
Losartan—CYP3A5—Daunorubicin—hematologic cancer	0.0076	0.0176	CbGbCtD
Losartan—SLCO1B3—Methotrexate—hematologic cancer	0.00751	0.0174	CbGbCtD
Losartan—CYP1A2—Carmustine—hematologic cancer	0.00732	0.017	CbGbCtD
Losartan—ALB—Imatinib—hematologic cancer	0.00725	0.0168	CbGbCtD
Losartan—CYP2C9—Idarubicin—hematologic cancer	0.00721	0.0167	CbGbCtD
Losartan—CYP3A5—Thalidomide—hematologic cancer	0.00693	0.0161	CbGbCtD
Losartan—CYP3A5—Teniposide—hematologic cancer	0.00661	0.0153	CbGbCtD
Losartan—CYP2C19—Bortezomib—hematologic cancer	0.00641	0.0149	CbGbCtD
Losartan—CYP1A2—Methoxsalen—hematologic cancer	0.00622	0.0144	CbGbCtD
Losartan—CYP3A5—Ifosfamide—hematologic cancer	0.0061	0.0141	CbGbCtD
Losartan—CYP1A2—Bortezomib—hematologic cancer	0.00592	0.0137	CbGbCtD
Losartan—CYP2C8—Ifosfamide—hematologic cancer	0.00586	0.0136	CbGbCtD
Losartan—CYP3A5—Imatinib—hematologic cancer	0.00582	0.0135	CbGbCtD
Losartan—CYP1A2—Daunorubicin—hematologic cancer	0.00566	0.0131	CbGbCtD
Losartan—CYP2C19—Thalidomide—hematologic cancer	0.00559	0.013	CbGbCtD
Losartan—CYP1A2—Alitretinoin—hematologic cancer	0.00554	0.0129	CbGbCtD
Losartan—CYP2C9—Bortezomib—hematologic cancer	0.00533	0.0124	CbGbCtD
Losartan—CYP2C19—Teniposide—hematologic cancer	0.00533	0.0124	CbGbCtD
Losartan—CYP1A2—Thalidomide—hematologic cancer	0.00515	0.012	CbGbCtD
Losartan—CYP2C8—Nilotinib—hematologic cancer	0.00509	0.0118	CbGbCtD
Losartan—CYP3A4—Bexarotene—hematologic cancer	0.00506	0.0117	CbGbCtD
Losartan—ABCB1—Daunorubicin—hematologic cancer	0.00495	0.0115	CbGbCtD
Losartan—CYP2C19—Ifosfamide—hematologic cancer	0.00492	0.0114	CbGbCtD
Losartan—ABCB1—Alitretinoin—hematologic cancer	0.00485	0.0112	CbGbCtD
Losartan—ALB—Prednisone—hematologic cancer	0.00477	0.0111	CbGbCtD
Losartan—CYP3A4—Lomustine—hematologic cancer	0.0047	0.0109	CbGbCtD
Losartan—CYP3A4—Busulfan—hematologic cancer	0.0047	0.0109	CbGbCtD
Losartan—CYP2C19—Imatinib—hematologic cancer	0.0047	0.0109	CbGbCtD
Losartan—CYP3A5—Dasatinib—hematologic cancer	0.00468	0.0109	CbGbCtD
Losartan—CYP2C9—Thalidomide—hematologic cancer	0.00464	0.0108	CbGbCtD
Losartan—ALB—Irinotecan—hematologic cancer	0.00453	0.0105	CbGbCtD
Losartan—CYP1A2—Dacarbazine—hematologic cancer	0.00443	0.0103	CbGbCtD
Losartan—CYP2C9—Teniposide—hematologic cancer	0.00443	0.0103	CbGbCtD
Losartan—SLCO1B1—Methotrexate—hematologic cancer	0.00437	0.0101	CbGbCtD
Losartan—CYP1A2—Imatinib—hematologic cancer	0.00434	0.0101	CbGbCtD
Losartan—CYP3A4—Thiotepa—hematologic cancer	0.00419	0.00972	CbGbCtD
Losartan—CYP2C9—Ifosfamide—hematologic cancer	0.00409	0.00949	CbGbCtD
Losartan—CYP2C9—Imatinib—hematologic cancer	0.00391	0.00906	CbGbCtD
Losartan—ABCB1—Imatinib—hematologic cancer	0.00379	0.0088	CbGbCtD
Losartan—CYP3A5—Irinotecan—hematologic cancer	0.00364	0.00844	CbGbCtD
Losartan—CYP2C9—Nilotinib—hematologic cancer	0.00355	0.00824	CbGbCtD
Losartan—CYP1A2—Dasatinib—hematologic cancer	0.00348	0.00808	CbGbCtD
Losartan—ABCB1—Nilotinib—hematologic cancer	0.00344	0.00799	CbGbCtD
Losartan—ABCB1—Vinorelbine—hematologic cancer	0.00342	0.00793	CbGbCtD
Losartan—CYP3A4—Methoxsalen—hematologic cancer	0.00326	0.00756	CbGbCtD
Losartan—CYP3A5—Vincristine—hematologic cancer	0.00318	0.00738	CbGbCtD
Losartan—CYP3A4—Bortezomib—hematologic cancer	0.0031	0.00719	CbGbCtD
Losartan—CYP2C19—Prednisone—hematologic cancer	0.0031	0.00718	CbGbCtD
Losartan—ABCB1—Dasatinib—hematologic cancer	0.00304	0.00706	CbGbCtD
Losartan—ABCB1—Mitoxantrone—hematologic cancer	0.00301	0.00698	CbGbCtD
Losartan—CYP3A4—Daunorubicin—hematologic cancer	0.00297	0.00688	CbGbCtD
Losartan—CYP3A5—Etoposide—hematologic cancer	0.00291	0.00676	CbGbCtD
Losartan—SLC22A6—Methotrexate—hematologic cancer	0.00281	0.00653	CbGbCtD
Losartan—CYP2C8—Etoposide—hematologic cancer	0.0028	0.0065	CbGbCtD
Losartan—ABCB1—Betamethasone—hematologic cancer	0.00268	0.00622	CbGbCtD
Losartan—ABCB1—Gemcitabine—hematologic cancer	0.00266	0.00616	CbGbCtD
Losartan—ABCB1—Prednisolone—hematologic cancer	0.00264	0.00614	CbGbCtD
Losartan—CYP3A4—Cytarabine—hematologic cancer	0.00262	0.00607	CbGbCtD
Losartan—CYP3A4—Teniposide—hematologic cancer	0.00258	0.00598	CbGbCtD
Losartan—ABCB1—Prednisone—hematologic cancer	0.0025	0.00579	CbGbCtD
Losartan—CYP3A5—Dexamethasone—hematologic cancer	0.0024	0.00556	CbGbCtD
Losartan—ALB—Methotrexate—hematologic cancer	0.0024	0.00556	CbGbCtD
Losartan—CYP3A4—Ifosfamide—hematologic cancer	0.00238	0.00552	CbGbCtD
Losartan—ABCB1—Irinotecan—hematologic cancer	0.00237	0.00549	CbGbCtD
Losartan—CYP2C8—Dexamethasone—hematologic cancer	0.0023	0.00534	CbGbCtD
Losartan—CYP3A4—Imatinib—hematologic cancer	0.00227	0.00527	CbGbCtD
Losartan—CYP1A2—Etoposide—hematologic cancer	0.00217	0.00503	CbGbCtD
Losartan—CYP3A4—Ruxolitinib—hematologic cancer	0.00214	0.00496	CbGbCtD
Losartan—ABCB1—Vinblastine—hematologic cancer	0.00211	0.00488	CbGbCtD
Losartan—ABCB1—Vincristine—hematologic cancer	0.00207	0.0048	CbGbCtD
Losartan—CYP3A4—Nilotinib—hematologic cancer	0.00206	0.00479	CbGbCtD
Losartan—CYP3A4—Vinorelbine—hematologic cancer	0.00205	0.00475	CbGbCtD
Losartan—CYP2C9—Cisplatin—hematologic cancer	0.00199	0.00461	CbGbCtD
Losartan—CYP2C19—Dexamethasone—hematologic cancer	0.00193	0.00448	CbGbCtD
Losartan—ABCB1—Cisplatin—hematologic cancer	0.00193	0.00448	CbGbCtD
Losartan—ABCB1—Etoposide—hematologic cancer	0.0019	0.0044	CbGbCtD
Losartan—CYP3A4—Triamcinolone—hematologic cancer	0.00187	0.00434	CbGbCtD
Losartan—CYP3A4—Dasatinib—hematologic cancer	0.00182	0.00423	CbGbCtD
Losartan—CYP3A4—Mitoxantrone—hematologic cancer	0.0018	0.00418	CbGbCtD
Losartan—CYP2C9—Dexamethasone—hematologic cancer	0.00161	0.00373	CbGbCtD
Losartan—CYP3A4—Betamethasone—hematologic cancer	0.00161	0.00373	CbGbCtD
Losartan—CYP3A4—Prednisolone—hematologic cancer	0.00158	0.00368	CbGbCtD
Losartan—ABCB1—Dexamethasone—hematologic cancer	0.00156	0.00362	CbGbCtD
Losartan—CYP3A4—Prednisone—hematologic cancer	0.0015	0.00347	CbGbCtD
Losartan—SLC2A9—blood—hematologic cancer	0.00149	0.0684	CbGeAlD
Losartan—CYP3A4—Irinotecan—hematologic cancer	0.00142	0.00329	CbGbCtD
Losartan—SLC2A9—lung—hematologic cancer	0.0013	0.06	CbGeAlD
Losartan—ABCB1—Doxorubicin—hematologic cancer	0.00129	0.003	CbGbCtD
Losartan—CYP3A4—Vinblastine—hematologic cancer	0.00126	0.00293	CbGbCtD
Losartan—ABCB1—Methotrexate—hematologic cancer	0.00125	0.00291	CbGbCtD
Losartan—CYP3A4—Vincristine—hematologic cancer	0.00124	0.00288	CbGbCtD
Losartan—SLC2A9—testis—hematologic cancer	0.00123	0.0566	CbGeAlD
Losartan—CYP3A4—Etoposide—hematologic cancer	0.00114	0.00264	CbGbCtD
Losartan—UGT1A1—hematopoietic system—hematologic cancer	0.000985	0.0453	CbGeAlD
Losartan—CYP3A4—Dexamethasone—hematologic cancer	0.000934	0.00217	CbGbCtD
Losartan—SLC2A9—lymph node—hematologic cancer	0.000891	0.041	CbGeAlD
Losartan—AGTR1—hematopoietic system—hematologic cancer	0.00086	0.0396	CbGeAlD
Losartan—Irbesartan—JUN—hematologic cancer	0.000825	0.519	CrCbGaD
Losartan—SLCO1B3—lung—hematologic cancer	0.000823	0.0379	CbGeAlD
Losartan—SLCO1B1—hematopoietic system—hematologic cancer	0.00082	0.0377	CbGeAlD
Losartan—CYP3A4—Doxorubicin—hematologic cancer	0.000775	0.0018	CbGbCtD
Losartan—UGT1A1—blood—hematologic cancer	0.000653	0.03	CbGeAlD
Losartan—UGT2B7—testis—hematologic cancer	0.000635	0.0292	CbGeAlD
Losartan—ACE—hematopoietic system—hematologic cancer	0.000635	0.0292	CbGeAlD
Losartan—AGTR1—blood—hematologic cancer	0.00057	0.0262	CbGeAlD
Losartan—SLCO1B1—blood—hematologic cancer	0.000543	0.025	CbGeAlD
Losartan—CYP2C19—hematopoietic system—hematologic cancer	0.000534	0.0246	CbGeAlD
Losartan—AGTR1—lung—hematologic cancer	0.000499	0.023	CbGeAlD
Losartan—ACE—gonad—hematologic cancer	0.000483	0.0222	CbGeAlD
Losartan—AGTR1—testis—hematologic cancer	0.000471	0.0217	CbGeAlD
Losartan—CYP2C8—hematopoietic system—hematologic cancer	0.000466	0.0214	CbGeAlD
Losartan—CYP1A2—hematopoietic system—hematologic cancer	0.000436	0.0201	CbGeAlD
Losartan—CYP3A5—hematopoietic system—hematologic cancer	0.000421	0.0194	CbGeAlD
Losartan—ACE—blood—hematologic cancer	0.000421	0.0194	CbGeAlD
Losartan—CYP2C9—hematopoietic system—hematologic cancer	0.000414	0.0191	CbGeAlD
Losartan—ACE—bone marrow—hematologic cancer	0.000407	0.0187	CbGeAlD
Losartan—ACE—lung—hematologic cancer	0.000369	0.017	CbGeAlD
Losartan—ALB—testis—hematologic cancer	0.000363	0.0167	CbGeAlD
Losartan—CYP2C19—blood—hematologic cancer	0.000354	0.0163	CbGeAlD
Losartan—ACE—testis—hematologic cancer	0.000348	0.016	CbGeAlD
Losartan—Telmisartan—ABCG2—hematologic cancer	0.000344	0.217	CrCbGaD
Losartan—AGTR1—lymph node—hematologic cancer	0.000341	0.0157	CbGeAlD
Losartan—CYP3A4—hematopoietic system—hematologic cancer	0.000316	0.0145	CbGeAlD
Losartan—CYP2C8—blood—hematologic cancer	0.000309	0.0142	CbGeAlD
Losartan—CYP1A2—blood—hematologic cancer	0.000289	0.0133	CbGeAlD
Losartan—CYP3A5—blood—hematologic cancer	0.000279	0.0128	CbGeAlD
Losartan—CYP2C9—blood—hematologic cancer	0.000274	0.0126	CbGeAlD
Losartan—ALB—lymph node—hematologic cancer	0.000263	0.0121	CbGeAlD
Losartan—CYP2C8—testis—hematologic cancer	0.000255	0.0118	CbGeAlD
Losartan—CYP1A2—lung—hematologic cancer	0.000253	0.0117	CbGeAlD
Losartan—ACE—lymph node—hematologic cancer	0.000252	0.0116	CbGeAlD
Losartan—CYP3A5—lung—hematologic cancer	0.000244	0.0112	CbGeAlD
Losartan—ABCB1—hematopoietic system—hematologic cancer	0.000223	0.0103	CbGeAlD
Losartan—CYP3A4—blood—hematologic cancer	0.000209	0.00963	CbGeAlD
Losartan—ABCB1—gonad—hematologic cancer	0.00017	0.00782	CbGeAlD
Losartan—Valsartan—ALB—hematologic cancer	0.00016	0.101	CrCbGaD
Losartan—ABCB1—blood—hematologic cancer	0.000148	0.00681	CbGeAlD
Losartan—Telmisartan—ABCB1—hematologic cancer	0.000143	0.0903	CrCbGaD
Losartan—ABCB1—bone marrow—hematologic cancer	0.000143	0.00659	CbGeAlD
Losartan—ABCB1—lung—hematologic cancer	0.00013	0.00597	CbGeAlD
Losartan—ABCB1—testis—hematologic cancer	0.000122	0.00564	CbGeAlD
Losartan—Candesartan—ABCB1—hematologic cancer	0.000116	0.0728	CrCbGaD
Losartan—ABCB1—lymph node—hematologic cancer	8.88e-05	0.00409	CbGeAlD
Losartan—Nervous system disorder—Prednisone—hematologic cancer	1.78e-05	0.000101	CcSEcCtD
Losartan—Tachycardia—Prednisone—hematologic cancer	1.77e-05	0.0001	CcSEcCtD
Losartan—Alopecia—Epirubicin—hematologic cancer	1.76e-05	0.0001	CcSEcCtD
Losartan—Nausea—Gemcitabine—hematologic cancer	1.76e-05	9.98e-05	CcSEcCtD
Losartan—Vomiting—Cisplatin—hematologic cancer	1.76e-05	9.95e-05	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—hematologic cancer	1.75e-05	9.94e-05	CcSEcCtD
Losartan—Vision blurred—Methotrexate—hematologic cancer	1.75e-05	9.92e-05	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—hematologic cancer	1.75e-05	9.9e-05	CcSEcCtD
Losartan—Rash—Cisplatin—hematologic cancer	1.74e-05	9.87e-05	CcSEcCtD
Losartan—Dermatitis—Cisplatin—hematologic cancer	1.74e-05	9.86e-05	CcSEcCtD
Losartan—Erythema—Epirubicin—hematologic cancer	1.74e-05	9.85e-05	CcSEcCtD
Losartan—Diarrhoea—Etoposide—hematologic cancer	1.73e-05	9.81e-05	CcSEcCtD
Losartan—Anorexia—Prednisone—hematologic cancer	1.73e-05	9.8e-05	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—hematologic cancer	1.72e-05	9.77e-05	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—hematologic cancer	1.72e-05	9.76e-05	CcSEcCtD
Losartan—Anaemia—Methotrexate—hematologic cancer	1.72e-05	9.73e-05	CcSEcCtD
Losartan—Feeling abnormal—Betamethasone—hematologic cancer	1.72e-05	9.73e-05	CcSEcCtD
Losartan—Feeling abnormal—Dexamethasone—hematologic cancer	1.72e-05	9.73e-05	CcSEcCtD
Losartan—Flushing—Doxorubicin—hematologic cancer	1.71e-05	9.72e-05	CcSEcCtD
Losartan—Flatulence—Epirubicin—hematologic cancer	1.71e-05	9.71e-05	CcSEcCtD
Losartan—Tension—Epirubicin—hematologic cancer	1.71e-05	9.67e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.7e-05	9.65e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Betamethasone—hematologic cancer	1.7e-05	9.65e-05	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—hematologic cancer	1.7e-05	9.65e-05	CcSEcCtD
Losartan—Hypersensitivity—Triamcinolone—hematologic cancer	1.69e-05	9.58e-05	CcSEcCtD
Losartan—Nervousness—Epirubicin—hematologic cancer	1.69e-05	9.57e-05	CcSEcCtD
Losartan—Back pain—Epirubicin—hematologic cancer	1.68e-05	9.53e-05	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—hematologic cancer	1.68e-05	9.5e-05	CcSEcCtD
Losartan—Malaise—Methotrexate—hematologic cancer	1.68e-05	9.49e-05	CcSEcCtD
Losartan—Dizziness—Etoposide—hematologic cancer	1.67e-05	9.48e-05	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—hematologic cancer	1.67e-05	9.47e-05	CcSEcCtD
Losartan—Vertigo—Methotrexate—hematologic cancer	1.67e-05	9.46e-05	CcSEcCtD
Losartan—Leukopenia—Methotrexate—hematologic cancer	1.66e-05	9.42e-05	CcSEcCtD
Losartan—Urticaria—Betamethasone—hematologic cancer	1.65e-05	9.38e-05	CcSEcCtD
Losartan—Urticaria—Dexamethasone—hematologic cancer	1.65e-05	9.38e-05	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.65e-05	9.36e-05	CcSEcCtD
Losartan—Dizziness—Prednisolone—hematologic cancer	1.65e-05	9.35e-05	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—hematologic cancer	1.65e-05	9.35e-05	CcSEcCtD
Losartan—Asthenia—Triamcinolone—hematologic cancer	1.65e-05	9.33e-05	CcSEcCtD
Losartan—Body temperature increased—Betamethasone—hematologic cancer	1.65e-05	9.33e-05	CcSEcCtD
Losartan—Abdominal pain—Betamethasone—hematologic cancer	1.65e-05	9.33e-05	CcSEcCtD
Losartan—Abdominal pain—Dexamethasone—hematologic cancer	1.65e-05	9.33e-05	CcSEcCtD
Losartan—Body temperature increased—Dexamethasone—hematologic cancer	1.65e-05	9.33e-05	CcSEcCtD
Losartan—Nausea—Cisplatin—hematologic cancer	1.64e-05	9.3e-05	CcSEcCtD
Losartan—Insomnia—Prednisone—hematologic cancer	1.64e-05	9.3e-05	CcSEcCtD
Losartan—Vision blurred—Epirubicin—hematologic cancer	1.64e-05	9.28e-05	CcSEcCtD
Losartan—Alopecia—Doxorubicin—hematologic cancer	1.63e-05	9.25e-05	CcSEcCtD
Losartan—Paraesthesia—Prednisone—hematologic cancer	1.63e-05	9.23e-05	CcSEcCtD
Losartan—Pruritus—Triamcinolone—hematologic cancer	1.62e-05	9.2e-05	CcSEcCtD
Losartan—Cough—Methotrexate—hematologic cancer	1.62e-05	9.18e-05	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—hematologic cancer	1.61e-05	9.14e-05	CcSEcCtD
Losartan—Vomiting—Etoposide—hematologic cancer	1.61e-05	9.12e-05	CcSEcCtD
Losartan—Erythema—Doxorubicin—hematologic cancer	1.61e-05	9.11e-05	CcSEcCtD
Losartan—Anaemia—Epirubicin—hematologic cancer	1.61e-05	9.1e-05	CcSEcCtD
Losartan—Agitation—Epirubicin—hematologic cancer	1.6e-05	9.05e-05	CcSEcCtD
Losartan—Dyspepsia—Prednisone—hematologic cancer	1.6e-05	9.05e-05	CcSEcCtD
Losartan—Rash—Etoposide—hematologic cancer	1.6e-05	9.04e-05	CcSEcCtD
Losartan—Dermatitis—Etoposide—hematologic cancer	1.59e-05	9.03e-05	CcSEcCtD
Losartan—Headache—Etoposide—hematologic cancer	1.59e-05	8.98e-05	CcSEcCtD
Losartan—Flatulence—Doxorubicin—hematologic cancer	1.59e-05	8.98e-05	CcSEcCtD
Losartan—Myalgia—Methotrexate—hematologic cancer	1.58e-05	8.96e-05	CcSEcCtD
Losartan—Chest pain—Methotrexate—hematologic cancer	1.58e-05	8.96e-05	CcSEcCtD
Losartan—Arthralgia—Methotrexate—hematologic cancer	1.58e-05	8.96e-05	CcSEcCtD
Losartan—Tension—Doxorubicin—hematologic cancer	1.58e-05	8.94e-05	CcSEcCtD
Losartan—Decreased appetite—Prednisone—hematologic cancer	1.58e-05	8.94e-05	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—hematologic cancer	1.58e-05	8.93e-05	CcSEcCtD
Losartan—Rash—Prednisolone—hematologic cancer	1.57e-05	8.92e-05	CcSEcCtD
Losartan—Dermatitis—Prednisolone—hematologic cancer	1.57e-05	8.91e-05	CcSEcCtD
Losartan—Malaise—Epirubicin—hematologic cancer	1.57e-05	8.88e-05	CcSEcCtD
Losartan—Fatigue—Prednisone—hematologic cancer	1.56e-05	8.86e-05	CcSEcCtD
Losartan—Headache—Prednisolone—hematologic cancer	1.56e-05	8.86e-05	CcSEcCtD
Losartan—Discomfort—Methotrexate—hematologic cancer	1.56e-05	8.85e-05	CcSEcCtD
Losartan—Nervousness—Doxorubicin—hematologic cancer	1.56e-05	8.85e-05	CcSEcCtD
Losartan—Vertigo—Epirubicin—hematologic cancer	1.56e-05	8.85e-05	CcSEcCtD
Losartan—Syncope—Epirubicin—hematologic cancer	1.56e-05	8.83e-05	CcSEcCtD
Losartan—Leukopenia—Epirubicin—hematologic cancer	1.56e-05	8.82e-05	CcSEcCtD
Losartan—Back pain—Doxorubicin—hematologic cancer	1.56e-05	8.82e-05	CcSEcCtD
Losartan—Constipation—Prednisone—hematologic cancer	1.55e-05	8.79e-05	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—hematologic cancer	1.55e-05	8.76e-05	CcSEcCtD
Losartan—Palpitations—Epirubicin—hematologic cancer	1.54e-05	8.7e-05	CcSEcCtD
Losartan—Confusional state—Methotrexate—hematologic cancer	1.53e-05	8.66e-05	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—hematologic cancer	1.53e-05	8.66e-05	CcSEcCtD
Losartan—Dizziness—Triamcinolone—hematologic cancer	1.52e-05	8.6e-05	CcSEcCtD
Losartan—Cough—Epirubicin—hematologic cancer	1.52e-05	8.6e-05	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—hematologic cancer	1.52e-05	8.59e-05	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—hematologic cancer	1.52e-05	8.59e-05	CcSEcCtD
Losartan—Infection—Methotrexate—hematologic cancer	1.51e-05	8.53e-05	CcSEcCtD
Losartan—Nausea—Etoposide—hematologic cancer	1.5e-05	8.52e-05	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Losartan—Asthenia—Dexamethasone—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Losartan—Asthenia—Betamethasone—hematologic cancer	1.49e-05	8.47e-05	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—hematologic cancer	1.49e-05	8.46e-05	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—hematologic cancer	1.49e-05	8.42e-05	CcSEcCtD
Losartan—Anaemia—Doxorubicin—hematologic cancer	1.49e-05	8.42e-05	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—hematologic cancer	1.48e-05	8.41e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—hematologic cancer	1.48e-05	8.4e-05	CcSEcCtD
Losartan—Nausea—Prednisolone—hematologic cancer	1.48e-05	8.4e-05	CcSEcCtD
Losartan—Chest pain—Epirubicin—hematologic cancer	1.48e-05	8.39e-05	CcSEcCtD
Losartan—Myalgia—Epirubicin—hematologic cancer	1.48e-05	8.39e-05	CcSEcCtD
Losartan—Arthralgia—Epirubicin—hematologic cancer	1.48e-05	8.39e-05	CcSEcCtD
Losartan—Agitation—Doxorubicin—hematologic cancer	1.48e-05	8.38e-05	CcSEcCtD
Losartan—Anxiety—Epirubicin—hematologic cancer	1.47e-05	8.36e-05	CcSEcCtD
Losartan—Pruritus—Dexamethasone—hematologic cancer	1.47e-05	8.35e-05	CcSEcCtD
Losartan—Pruritus—Betamethasone—hematologic cancer	1.47e-05	8.35e-05	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—hematologic cancer	1.47e-05	8.3e-05	CcSEcCtD
Losartan—Discomfort—Epirubicin—hematologic cancer	1.46e-05	8.29e-05	CcSEcCtD
Losartan—Vomiting—Triamcinolone—hematologic cancer	1.46e-05	8.27e-05	CcSEcCtD
Losartan—Malaise—Doxorubicin—hematologic cancer	1.45e-05	8.22e-05	CcSEcCtD
Losartan—Rash—Triamcinolone—hematologic cancer	1.45e-05	8.2e-05	CcSEcCtD
Losartan—Dry mouth—Epirubicin—hematologic cancer	1.45e-05	8.2e-05	CcSEcCtD
Losartan—Dermatitis—Triamcinolone—hematologic cancer	1.45e-05	8.19e-05	CcSEcCtD
Losartan—Vertigo—Doxorubicin—hematologic cancer	1.45e-05	8.19e-05	CcSEcCtD
Losartan—Anorexia—Methotrexate—hematologic cancer	1.45e-05	8.19e-05	CcSEcCtD
Losartan—Syncope—Doxorubicin—hematologic cancer	1.44e-05	8.17e-05	CcSEcCtD
Losartan—Urticaria—Prednisone—hematologic cancer	1.44e-05	8.17e-05	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—hematologic cancer	1.44e-05	8.16e-05	CcSEcCtD
Losartan—Headache—Triamcinolone—hematologic cancer	1.44e-05	8.15e-05	CcSEcCtD
Losartan—Abdominal pain—Prednisone—hematologic cancer	1.43e-05	8.13e-05	CcSEcCtD
Losartan—Body temperature increased—Prednisone—hematologic cancer	1.43e-05	8.13e-05	CcSEcCtD
Losartan—Confusional state—Epirubicin—hematologic cancer	1.43e-05	8.11e-05	CcSEcCtD
Losartan—Diarrhoea—Dexamethasone—hematologic cancer	1.43e-05	8.08e-05	CcSEcCtD
Losartan—Diarrhoea—Betamethasone—hematologic cancer	1.43e-05	8.08e-05	CcSEcCtD
Losartan—Palpitations—Doxorubicin—hematologic cancer	1.42e-05	8.05e-05	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—hematologic cancer	1.42e-05	8.04e-05	CcSEcCtD
Losartan—Oedema—Epirubicin—hematologic cancer	1.42e-05	8.04e-05	CcSEcCtD
Losartan—Hypotension—Methotrexate—hematologic cancer	1.42e-05	8.03e-05	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—hematologic cancer	1.41e-05	8.01e-05	CcSEcCtD
Losartan—Infection—Epirubicin—hematologic cancer	1.41e-05	7.99e-05	CcSEcCtD
Losartan—Cough—Doxorubicin—hematologic cancer	1.4e-05	7.95e-05	CcSEcCtD
Losartan—Shock—Epirubicin—hematologic cancer	1.4e-05	7.91e-05	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—hematologic cancer	1.39e-05	7.88e-05	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—hematologic cancer	1.39e-05	7.87e-05	CcSEcCtD
Losartan—Tachycardia—Epirubicin—hematologic cancer	1.38e-05	7.85e-05	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.38e-05	7.83e-05	CcSEcCtD
Losartan—Dizziness—Dexamethasone—hematologic cancer	1.38e-05	7.8e-05	CcSEcCtD
Losartan—Dizziness—Betamethasone—hematologic cancer	1.38e-05	7.8e-05	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—hematologic cancer	1.37e-05	7.77e-05	CcSEcCtD
Losartan—Insomnia—Methotrexate—hematologic cancer	1.37e-05	7.77e-05	CcSEcCtD
Losartan—Myalgia—Doxorubicin—hematologic cancer	1.37e-05	7.76e-05	CcSEcCtD
Losartan—Chest pain—Doxorubicin—hematologic cancer	1.37e-05	7.76e-05	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—hematologic cancer	1.37e-05	7.76e-05	CcSEcCtD
Losartan—Anxiety—Doxorubicin—hematologic cancer	1.36e-05	7.73e-05	CcSEcCtD
Losartan—Nausea—Triamcinolone—hematologic cancer	1.36e-05	7.73e-05	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—hematologic cancer	1.36e-05	7.71e-05	CcSEcCtD
Losartan—Discomfort—Doxorubicin—hematologic cancer	1.35e-05	7.67e-05	CcSEcCtD
Losartan—Anorexia—Epirubicin—hematologic cancer	1.35e-05	7.66e-05	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—hematologic cancer	1.35e-05	7.66e-05	CcSEcCtD
Losartan—Somnolence—Methotrexate—hematologic cancer	1.35e-05	7.64e-05	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—hematologic cancer	1.34e-05	7.59e-05	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—hematologic cancer	1.34e-05	7.57e-05	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—hematologic cancer	1.33e-05	7.56e-05	CcSEcCtD
Losartan—Hypotension—Epirubicin—hematologic cancer	1.33e-05	7.51e-05	CcSEcCtD
Losartan—Vomiting—Dexamethasone—hematologic cancer	1.32e-05	7.5e-05	CcSEcCtD
Losartan—Vomiting—Betamethasone—hematologic cancer	1.32e-05	7.5e-05	CcSEcCtD
Losartan—Confusional state—Doxorubicin—hematologic cancer	1.32e-05	7.5e-05	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—hematologic cancer	1.32e-05	7.47e-05	CcSEcCtD
Losartan—Rash—Betamethasone—hematologic cancer	1.31e-05	7.44e-05	CcSEcCtD
Losartan—Rash—Dexamethasone—hematologic cancer	1.31e-05	7.44e-05	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—hematologic cancer	1.31e-05	7.44e-05	CcSEcCtD
Losartan—Oedema—Doxorubicin—hematologic cancer	1.31e-05	7.44e-05	CcSEcCtD
Losartan—Dermatitis—Betamethasone—hematologic cancer	1.31e-05	7.43e-05	CcSEcCtD
Losartan—Dermatitis—Dexamethasone—hematologic cancer	1.31e-05	7.43e-05	CcSEcCtD
Losartan—Fatigue—Methotrexate—hematologic cancer	1.31e-05	7.41e-05	CcSEcCtD
Losartan—Headache—Dexamethasone—hematologic cancer	1.3e-05	7.39e-05	CcSEcCtD
Losartan—Headache—Betamethasone—hematologic cancer	1.3e-05	7.39e-05	CcSEcCtD
Losartan—Infection—Doxorubicin—hematologic cancer	1.3e-05	7.39e-05	CcSEcCtD
Losartan—Asthenia—Prednisone—hematologic cancer	1.3e-05	7.37e-05	CcSEcCtD
Losartan—Pain—Methotrexate—hematologic cancer	1.3e-05	7.35e-05	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Losartan—Shock—Doxorubicin—hematologic cancer	1.29e-05	7.32e-05	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—hematologic cancer	1.29e-05	7.29e-05	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—hematologic cancer	1.29e-05	7.28e-05	CcSEcCtD
Losartan—Pruritus—Prednisone—hematologic cancer	1.28e-05	7.27e-05	CcSEcCtD
Losartan—Insomnia—Epirubicin—hematologic cancer	1.28e-05	7.27e-05	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—hematologic cancer	1.28e-05	7.26e-05	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—hematologic cancer	1.27e-05	7.22e-05	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—hematologic cancer	1.27e-05	7.19e-05	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—hematologic cancer	1.26e-05	7.17e-05	CcSEcCtD
Losartan—Somnolence—Epirubicin—hematologic cancer	1.26e-05	7.15e-05	CcSEcCtD
Losartan—Anorexia—Doxorubicin—hematologic cancer	1.25e-05	7.09e-05	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—hematologic cancer	1.25e-05	7.08e-05	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—hematologic cancer	1.25e-05	7.08e-05	CcSEcCtD
Losartan—Diarrhoea—Prednisone—hematologic cancer	1.24e-05	7.03e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—hematologic cancer	1.24e-05	7.02e-05	CcSEcCtD
Losartan—Nausea—Betamethasone—hematologic cancer	1.24e-05	7.01e-05	CcSEcCtD
Losartan—Nausea—Dexamethasone—hematologic cancer	1.24e-05	7.01e-05	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—hematologic cancer	1.23e-05	6.99e-05	CcSEcCtD
Losartan—Hypotension—Doxorubicin—hematologic cancer	1.23e-05	6.95e-05	CcSEcCtD
Losartan—Fatigue—Epirubicin—hematologic cancer	1.22e-05	6.93e-05	CcSEcCtD
Losartan—Constipation—Epirubicin—hematologic cancer	1.21e-05	6.87e-05	CcSEcCtD
Losartan—Pain—Epirubicin—hematologic cancer	1.21e-05	6.87e-05	CcSEcCtD
Losartan—Urticaria—Methotrexate—hematologic cancer	1.2e-05	6.82e-05	CcSEcCtD
Losartan—Dizziness—Prednisone—hematologic cancer	1.2e-05	6.8e-05	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—hematologic cancer	1.2e-05	6.79e-05	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—hematologic cancer	1.2e-05	6.79e-05	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.2e-05	6.78e-05	CcSEcCtD
Losartan—Insomnia—Doxorubicin—hematologic cancer	1.19e-05	6.73e-05	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—hematologic cancer	1.18e-05	6.68e-05	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—hematologic cancer	1.17e-05	6.63e-05	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—hematologic cancer	1.17e-05	6.62e-05	CcSEcCtD
Losartan—Somnolence—Doxorubicin—hematologic cancer	1.17e-05	6.61e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—hematologic cancer	1.16e-05	6.57e-05	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—hematologic cancer	1.16e-05	6.55e-05	CcSEcCtD
Losartan—Vomiting—Prednisone—hematologic cancer	1.15e-05	6.54e-05	CcSEcCtD
Losartan—Rash—Prednisone—hematologic cancer	1.14e-05	6.48e-05	CcSEcCtD
Losartan—Dermatitis—Prednisone—hematologic cancer	1.14e-05	6.47e-05	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—hematologic cancer	1.14e-05	6.47e-05	CcSEcCtD
Losartan—Headache—Prednisone—hematologic cancer	1.14e-05	6.44e-05	CcSEcCtD
Losartan—Fatigue—Doxorubicin—hematologic cancer	1.13e-05	6.41e-05	CcSEcCtD
Losartan—Urticaria—Epirubicin—hematologic cancer	1.13e-05	6.39e-05	CcSEcCtD
Losartan—Pain—Doxorubicin—hematologic cancer	1.12e-05	6.36e-05	CcSEcCtD
Losartan—Constipation—Doxorubicin—hematologic cancer	1.12e-05	6.36e-05	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—hematologic cancer	1.12e-05	6.35e-05	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—hematologic cancer	1.12e-05	6.35e-05	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—hematologic cancer	1.12e-05	6.33e-05	CcSEcCtD
Losartan—Asthenia—Methotrexate—hematologic cancer	1.09e-05	6.16e-05	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—hematologic cancer	1.08e-05	6.13e-05	CcSEcCtD
Losartan—Nausea—Prednisone—hematologic cancer	1.08e-05	6.11e-05	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.07e-05	6.08e-05	CcSEcCtD
Losartan—Pruritus—Methotrexate—hematologic cancer	1.07e-05	6.08e-05	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—hematologic cancer	1.05e-05	5.92e-05	CcSEcCtD
Losartan—Urticaria—Doxorubicin—hematologic cancer	1.04e-05	5.91e-05	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—hematologic cancer	1.04e-05	5.88e-05	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—hematologic cancer	1.04e-05	5.88e-05	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—hematologic cancer	1.04e-05	5.88e-05	CcSEcCtD
Losartan—Asthenia—Epirubicin—hematologic cancer	1.02e-05	5.77e-05	CcSEcCtD
Losartan—Pruritus—Epirubicin—hematologic cancer	1e-05	5.69e-05	CcSEcCtD
Losartan—Dizziness—Methotrexate—hematologic cancer	1e-05	5.68e-05	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—hematologic cancer	9.71e-06	5.5e-05	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—hematologic cancer	9.67e-06	5.48e-05	CcSEcCtD
Losartan—Vomiting—Methotrexate—hematologic cancer	9.64e-06	5.46e-05	CcSEcCtD
Losartan—Rash—Methotrexate—hematologic cancer	9.56e-06	5.42e-05	CcSEcCtD
Losartan—Dermatitis—Methotrexate—hematologic cancer	9.55e-06	5.41e-05	CcSEcCtD
Losartan—Headache—Methotrexate—hematologic cancer	9.5e-06	5.38e-05	CcSEcCtD
Losartan—Asthenia—Doxorubicin—hematologic cancer	9.42e-06	5.34e-05	CcSEcCtD
Losartan—Dizziness—Epirubicin—hematologic cancer	9.38e-06	5.32e-05	CcSEcCtD
Losartan—Pruritus—Doxorubicin—hematologic cancer	9.29e-06	5.26e-05	CcSEcCtD
Losartan—Vomiting—Epirubicin—hematologic cancer	9.02e-06	5.11e-05	CcSEcCtD
Losartan—Nausea—Methotrexate—hematologic cancer	9.01e-06	5.1e-05	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—hematologic cancer	8.98e-06	5.09e-05	CcSEcCtD
Losartan—Rash—Epirubicin—hematologic cancer	8.95e-06	5.07e-05	CcSEcCtD
Losartan—Dermatitis—Epirubicin—hematologic cancer	8.94e-06	5.06e-05	CcSEcCtD
Losartan—Headache—Epirubicin—hematologic cancer	8.89e-06	5.04e-05	CcSEcCtD
Losartan—Dizziness—Doxorubicin—hematologic cancer	8.68e-06	4.92e-05	CcSEcCtD
Losartan—Nausea—Epirubicin—hematologic cancer	8.43e-06	4.77e-05	CcSEcCtD
Losartan—Vomiting—Doxorubicin—hematologic cancer	8.35e-06	4.73e-05	CcSEcCtD
Losartan—Rash—Doxorubicin—hematologic cancer	8.28e-06	4.69e-05	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—hematologic cancer	8.27e-06	4.69e-05	CcSEcCtD
Losartan—Headache—Doxorubicin—hematologic cancer	8.22e-06	4.66e-05	CcSEcCtD
Losartan—Nausea—Doxorubicin—hematologic cancer	7.8e-06	4.42e-05	CcSEcCtD
Losartan—UGT1A1—Metabolism—ALB—hematologic cancer	2.39e-06	2.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1A—hematologic cancer	2.38e-06	2.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—hematologic cancer	2.38e-06	2.91e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HSP90AA1—hematologic cancer	2.38e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NUP98—hematologic cancer	2.37e-06	2.89e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—EP300—hematologic cancer	2.37e-06	2.89e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.34e-06	2.86e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.34e-06	2.85e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CREBBP—hematologic cancer	2.34e-06	2.85e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK8—hematologic cancer	2.33e-06	2.84e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.33e-06	2.84e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—hematologic cancer	2.32e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—hematologic cancer	2.32e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.3e-06	2.81e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.3e-06	2.81e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.3e-06	2.8e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NUP214—hematologic cancer	2.28e-06	2.79e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3R1—hematologic cancer	2.28e-06	2.79e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ACP5—hematologic cancer	2.28e-06	2.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CA9—hematologic cancer	2.28e-06	2.78e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NQO1—hematologic cancer	2.27e-06	2.77e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD44—hematologic cancer	2.27e-06	2.77e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EP300—hematologic cancer	2.27e-06	2.77e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.26e-06	2.76e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.25e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.25e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.25e-06	2.75e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—EP300—hematologic cancer	2.24e-06	2.74e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—hematologic cancer	2.24e-06	2.74e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.24e-06	2.73e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTR—hematologic cancer	2.24e-06	2.73e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.22e-06	2.72e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD44—hematologic cancer	2.22e-06	2.71e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NQO1—hematologic cancer	2.22e-06	2.71e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.21e-06	2.7e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SRC—hematologic cancer	2.21e-06	2.69e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.2e-06	2.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ENO2—hematologic cancer	2.19e-06	2.68e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—hematologic cancer	2.19e-06	2.67e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—SRC—hematologic cancer	2.18e-06	2.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.15e-06	2.63e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—hematologic cancer	2.15e-06	2.62e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYCS—hematologic cancer	2.15e-06	2.62e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—IDH1—hematologic cancer	2.14e-06	2.62e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.14e-06	2.61e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—hematologic cancer	2.14e-06	2.61e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.13e-06	2.61e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.13e-06	2.6e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—hematologic cancer	2.13e-06	2.6e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TXN—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—hematologic cancer	2.11e-06	2.58e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—hematologic cancer	2.11e-06	2.57e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—hematologic cancer	2.1e-06	2.56e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYCS—hematologic cancer	2.1e-06	2.56e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.1e-06	2.56e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.09e-06	2.55e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.08e-06	2.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SDC1—hematologic cancer	2.08e-06	2.54e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.07e-06	2.53e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NQO1—hematologic cancer	2.07e-06	2.53e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD44—hematologic cancer	2.07e-06	2.53e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.05e-06	2.51e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.04e-06	2.49e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—hematologic cancer	2.03e-06	2.48e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.03e-06	2.48e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—hematologic cancer	2.01e-06	2.45e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.01e-06	2.45e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—hematologic cancer	2e-06	2.44e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.99e-06	2.43e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.99e-06	2.43e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.99e-06	2.43e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—hematologic cancer	1.98e-06	2.41e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—hematologic cancer	1.97e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.96e-06	2.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYCS—hematologic cancer	1.96e-06	2.39e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—hematologic cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—hematologic cancer	1.94e-06	2.37e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NCOR1—hematologic cancer	1.94e-06	2.37e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.94e-06	2.37e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.94e-06	2.37e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.93e-06	2.36e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.92e-06	2.35e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.89e-06	2.31e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.89e-06	2.31e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.88e-06	2.29e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—hematologic cancer	1.86e-06	2.27e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—hematologic cancer	1.85e-06	2.26e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.83e-06	2.24e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NUP98—hematologic cancer	1.83e-06	2.23e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—hematologic cancer	1.83e-06	2.23e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—hematologic cancer	1.82e-06	2.22e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—hematologic cancer	1.8e-06	2.2e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.79e-06	2.19e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.78e-06	2.17e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.78e-06	2.17e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD44—hematologic cancer	1.77e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NQO1—hematologic cancer	1.77e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NUP214—hematologic cancer	1.76e-06	2.15e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.75e-06	2.14e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	1.75e-06	2.14e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—hematologic cancer	1.74e-06	2.12e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.73e-06	2.12e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTR—hematologic cancer	1.73e-06	2.11e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.73e-06	2.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.73e-06	2.11e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.72e-06	2.1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—hematologic cancer	1.71e-06	2.09e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—hematologic cancer	1.7e-06	2.07e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NCOR1—hematologic cancer	1.7e-06	2.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ENO2—hematologic cancer	1.69e-06	2.07e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-06	2.05e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYCS—hematologic cancer	1.67e-06	2.04e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.67e-06	2.04e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.67e-06	2.04e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.67e-06	2.04e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.66e-06	2.03e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—hematologic cancer	1.66e-06	2.03e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.64e-06	2.01e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.63e-06	2e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—hematologic cancer	1.62e-06	1.98e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SDC1—hematologic cancer	1.61e-06	1.96e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—hematologic cancer	1.6e-06	1.96e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—hematologic cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—hematologic cancer	1.58e-06	1.93e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—hematologic cancer	1.55e-06	1.9e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.55e-06	1.89e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.54e-06	1.88e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—hematologic cancer	1.53e-06	1.87e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.52e-06	1.85e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—hematologic cancer	1.52e-06	1.85e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-06	1.84e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—hematologic cancer	1.5e-06	1.83e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.5e-06	1.83e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—hematologic cancer	1.49e-06	1.82e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.48e-06	1.8e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.47e-06	1.79e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—hematologic cancer	1.45e-06	1.77e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.45e-06	1.77e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—hematologic cancer	1.44e-06	1.76e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—hematologic cancer	1.43e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.43e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.4e-06	1.71e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.4e-06	1.71e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.39e-06	1.69e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—hematologic cancer	1.37e-06	1.67e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD44—hematologic cancer	1.37e-06	1.67e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NQO1—hematologic cancer	1.37e-06	1.67e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.36e-06	1.66e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.36e-06	1.66e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.36e-06	1.66e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—hematologic cancer	1.35e-06	1.65e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.34e-06	1.64e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CREBBP—hematologic cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYCS—hematologic cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—hematologic cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.28e-06	1.56e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.27e-06	1.55e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—hematologic cancer	1.27e-06	1.55e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.26e-06	1.54e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—hematologic cancer	1.26e-06	1.53e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-06	1.51e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.2e-06	1.47e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.2e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.2e-06	1.46e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3R1—hematologic cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.18e-06	1.44e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.18e-06	1.44e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CREBBP—hematologic cancer	1.17e-06	1.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.14e-06	1.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.14e-06	1.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—hematologic cancer	1.12e-06	1.37e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.11e-06	1.35e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.11e-06	1.35e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—hematologic cancer	1.11e-06	1.35e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—hematologic cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—hematologic cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.09e-06	1.33e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.08e-06	1.32e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.07e-06	1.31e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.06e-06	1.29e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—hematologic cancer	1.06e-06	1.29e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—hematologic cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.05e-06	1.28e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.04e-06	1.26e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—hematologic cancer	1.02e-06	1.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.01e-06	1.23e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—hematologic cancer	9.9e-07	1.21e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3R1—hematologic cancer	9.78e-07	1.19e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—hematologic cancer	9.66e-07	1.18e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—hematologic cancer	9.61e-07	1.17e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—hematologic cancer	9.58e-07	1.17e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—hematologic cancer	9.53e-07	1.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CREBBP—hematologic cancer	9.33e-07	1.14e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—hematologic cancer	9.25e-07	1.13e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—hematologic cancer	9.14e-07	1.12e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—hematologic cancer	9.09e-07	1.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—hematologic cancer	9.03e-07	1.1e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.85e-07	1.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—hematologic cancer	8.74e-07	1.07e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—hematologic cancer	8.55e-07	1.04e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3R1—hematologic cancer	8.36e-07	1.02e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—hematologic cancer	8.35e-07	1.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—hematologic cancer	8.16e-07	9.97e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—hematologic cancer	7.96e-07	9.73e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—hematologic cancer	7.81e-07	9.54e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—hematologic cancer	7.8e-07	9.53e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.77e-07	9.49e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.71e-07	9.42e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—hematologic cancer	7.44e-07	9.09e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CREBBP—hematologic cancer	7.2e-07	8.8e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.83e-07	8.34e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—hematologic cancer	6.76e-07	8.26e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—hematologic cancer	6.74e-07	8.24e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—hematologic cancer	6.72e-07	8.21e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—hematologic cancer	6.67e-07	8.14e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6.45e-07	7.88e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—hematologic cancer	6.38e-07	7.79e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—hematologic cancer	6.36e-07	7.76e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—hematologic cancer	6.04e-07	7.37e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.95e-07	7.27e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.89e-07	7.2e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—hematologic cancer	5.52e-07	6.75e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—hematologic cancer	5.5e-07	6.72e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—hematologic cancer	5.49e-07	6.71e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—hematologic cancer	5.14e-07	6.28e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—hematologic cancer	4.93e-07	6.02e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—hematologic cancer	4.91e-07	5.99e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—hematologic cancer	4.81e-07	5.88e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.7e-07	5.74e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—hematologic cancer	4.5e-07	5.49e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—hematologic cancer	3.84e-07	4.69e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.63e-07	4.43e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—hematologic cancer	2.96e-07	3.62e-06	CbGpPWpGaD
